Indwiani Astuti

1.6k total citations · 1 hit paper
59 papers, 1.1k citations indexed

About

Indwiani Astuti is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Indwiani Astuti has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Indwiani Astuti's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Indwiani Astuti is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Indwiani Astuti collaborates with scholars based in Indonesia, Japan and Azerbaijan. Indwiani Astuti's co-authors include Ysrafil Ysrafil, Yuliani Setyaningsih, Adi Heru Husodo, Sofia Mubarika Haryana, Rainy Umbas, Muthmainah Muthmainah, Dono Indarto, Harapan Harapan, Ahmad Hamim Sadewa and Imran Imran and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Nutrition and Tumor Biology.

In The Last Decade

Indwiani Astuti

55 papers receiving 1.0k citations

Hit Papers

Severe Acute Respiratory ... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indwiani Astuti Indonesia 10 542 323 121 117 89 59 1.1k
Kamalendra Singh United States 17 572 1.1× 465 1.4× 62 0.5× 88 0.8× 85 1.0× 34 1.3k
Ysrafil Ysrafil Indonesia 7 536 1.0× 243 0.8× 118 1.0× 115 1.0× 73 0.8× 25 857
Aftab Alam India 15 354 0.7× 524 1.6× 90 0.7× 64 0.5× 113 1.3× 44 1.1k
Yunjiao Zhou China 15 573 1.1× 390 1.2× 223 1.8× 50 0.4× 102 1.1× 27 1.3k
Jonaid Ahmad Malik India 17 270 0.5× 268 0.8× 52 0.4× 58 0.5× 67 0.8× 39 786
Jianyong Zhu China 9 406 0.7× 137 0.4× 89 0.7× 50 0.4× 68 0.8× 15 703
Deqing Yang China 11 523 1.0× 232 0.7× 229 1.9× 52 0.4× 80 0.9× 15 1.0k
Manman Geng China 12 885 1.6× 330 1.0× 300 2.5× 52 0.4× 168 1.9× 19 1.5k
Shih-Hwa Chiou Taiwan 5 399 0.7× 195 0.6× 98 0.8× 76 0.6× 41 0.5× 11 683
Xianyue Wang China 9 1.3k 2.4× 442 1.4× 213 1.8× 158 1.4× 138 1.6× 13 1.9k

Countries citing papers authored by Indwiani Astuti

Since Specialization
Citations

This map shows the geographic impact of Indwiani Astuti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indwiani Astuti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indwiani Astuti more than expected).

Fields of papers citing papers by Indwiani Astuti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indwiani Astuti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indwiani Astuti. The network helps show where Indwiani Astuti may publish in the future.

Co-authorship network of co-authors of Indwiani Astuti

This figure shows the co-authorship network connecting the top 25 collaborators of Indwiani Astuti. A scholar is included among the top collaborators of Indwiani Astuti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indwiani Astuti. Indwiani Astuti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Astuti, Indwiani, et al.. (2024). Methylcobalamin as a candidate for chronic peripheral neuropathic pain therapy: review of molecular pharmacology actiona. The Korean journal of pain. 37(4). 299–309. 1 indexed citations
3.
Ysrafil, Ysrafil, et al.. (2023). Mosaic vaccine design targeting mutational spike protein of SARS- CoV-2: An immunoinformatics approach. Bioimpacts. 15. 26443–26443. 3 indexed citations
4.
Ysrafil, Ysrafil & Indwiani Astuti. (2021). Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression. Bioimpacts. 12(3). 195–202. 8 indexed citations
5.
Astuti, Indwiani, et al.. (2021). The Potential of hsa-mir-106b-5p as Liquid Biomarker in Prostate Cancer Patients in Indonesia. Asian Pacific Journal of Cancer Prevention. 22(3). 837–842. 7 indexed citations
6.
Astuti, Indwiani, et al.. (2021). The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review. Journal of Pharmaceutical Analysis. 11(3). 265–271. 18 indexed citations
7.
Astuti, Indwiani, et al.. (2021). Cytokines as Prognostic Biomarkers of Epithelial Ovarian Cancer (EOC): A Systematic Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention. 22(2). 315–323. 11 indexed citations
8.
Astuti, Indwiani & Ysrafil Ysrafil. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(4). 407–412. 737 indexed citations breakdown →
9.
Astuti, Indwiani, et al.. (2019). Urine miR-21-5p and miR-200c-3p as potential non-invasive biomarkers in patients with prostate cancer. SHILAP Revista de lepidopterología. 46(1). 26–30. 34 indexed citations
10.
Astuti, Indwiani, et al.. (2019). Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines. Asian Pacific Journal of Cancer Prevention. 20(6). 1667–1673. 36 indexed citations
11.
Setyaningsih, Yuliani, Adi Heru Husodo, & Indwiani Astuti. (2018). Work Environment Factors and Their Influence on Urinary Chromium Levels in Informal Electroplating Workers. SHILAP Revista de lepidopterología. 31. 6007–6007. 3 indexed citations
12.
Haryana, Sofia Mubarika, et al.. (2018). The role of insulin receptor substrate 1 gene polymorphism Gly972Arg as a risk factor for ischemic stroke among Indonesian subjects. BMC Research Notes. 11(1). 718–718. 4 indexed citations
13.
Astuti, Indwiani, et al.. (2018). Dust Exposures, IgE Levels, History of Allergy, and Symptoms of Allergy in Poultry Workers. SHILAP Revista de lepidopterología. 14(1). 34–40. 1 indexed citations
14.
Astuti, Indwiani, et al.. (2017). Epidemiologic profile of oral squamous cell carcinoma in Yogyakarta, Indonesia. SHILAP Revista de lepidopterología. 29(1). 5 indexed citations
15.
Huang, Wen-Chien, Wei‐Hwa Lee, Oluwaseun Adebayo Bamodu, et al.. (2017). Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication. Tumor Biology. 39(5). 3726130768–3726130768. 11 indexed citations
16.
Sudargo, Toto, et al.. (2017). The Effect of Kersen Juice on Lipid Profile of Spargue Dawley Rats: A Randomized Controlled Trial. 9(3). 97–103. 2 indexed citations
19.
Sunarti, Sunarti, et al.. (2012). Efek asupan vitamin D terhadap tekanan darah sistolik tikus putih (Rattus norvegicus) = The effect of vitamin D intake on systolic blood pressure of Rattus norvegicus. Jurnal Gizi Klinik Indonesia. 9(2012).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026